Viewing Study NCT05009069


Ignite Creation Date: 2025-12-24 @ 10:58 PM
Ignite Modification Date: 2026-01-02 @ 9:01 AM
Study NCT ID: NCT05009069
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-14
First Post: 2021-08-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module